(S (NP-SBJ (JJ Nasal) (NP-COOD (NP (NN NK-) (NP (-NONE- *?*))) (CC and) (NP (NN T-cell))) (NNS lymphomas)) (VP (VBP share) (NP (NP (DT the) (JJ same) (NN type)) (PP (IN of) (NP (JJ Epstein-Barr) (NN virus) (NN latency))) (PP (IN as) (NP-COOD (NP (JJ nasopharyngeal) (NN carcinoma)) (CC and) (NP (NP (NN Hodgkin) (POS 's)) (NN disease)))))) (. .))
(S (NP-SBJ-72 (JJ Nasal) (JJ (NK-cell T)) (NNS lymphomas)) (VP (MD can) (VP (VB be) (VP (ADVP (RBR further)) (VBN separated) (NP (-NONE- *-72)) (PP (IN into) (NP (NP (DT those)) (PP-COOD (PP (IN of) (NP (NP (NP (JJ natural) (NN killer)) (PRN (-LRB- -LRB-) (NP (NN NK)) (-RRB- -RRB-))) (NN cell) (NN lineage))) (CC or) (PP (IN of) (NP (NN T-cell) (NN lineage)))) (, ,) (PP (IN with) (NP (NP (NNS differences)) (PP (IN in) (NP-COOD (NP (JJ cellular) (NN phenotype)) (, ,) (NP (NP (NP (NN T-cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TcR)) (-RRB- -RRB-))) (NN gene) (NN rearrangement)) (CC and) (NP (NN TcR) (NN transcript) (NN expression))))))))))) (. .))
(S (NP-SBJ-73 (NP-COOD (CC Both) (NP (NN NK-) (NP (-NONE- *?*))) (CC and) (NP (NN T-cell))) (NNS subtypes)) (VP (VBP are) (VP (ADVP (RB closely)) (VBN associated) (NP (-NONE- *-73)) (PP (IN with) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ-74 (NN EBV) (NN gene) (NN expression)) (VP (VBD was) (VP (VBN determined) (NP (-NONE- *-74)) (PP (IN in) (NP (NP (CD 23) (NNS cases)) (PP (IN of) (NP (NP (JJ nasal) (NN lymphoma)) (PRN (-LRB- -LRB-) (NP (NN NL)) (-RRB- -RRB-)))))) (PP (IN by) (NP-LGS-COOD (NP (NP (ADJP (FW in) (FW situ)) (NN hybridisation)) (PRN (-LRB- -LRB-) (NP (NN ISH)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ reverse) (NN transcriptase-polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-))) (CC and) (NP (NP (NN immunohistochemistry)) (PRN (-LRB- -LRB-) (NP (NN IH)) (-RRB- -RRB-))))))) (. .))
(S (PP-TPC-75 (IN Of) (NP (DT the) (CD 23) (NNS cases))) (, ,) (S-COOD (S (NP-SBJ-76 (NP (CD 19)) (PP (-NONE- *T*-75))) (VP (VBD were) (VP (VBN classified) (NP (-NONE- *-76)) (PP-78 (IN as) (NN NK-cell))))) (CC and) (S (NP-SBJ=76 (NP (CD 4)) (PP (-NONE- *T*-75))) (PP=78 (IN as) (NP (NN T-cell) (NNS tumours))))) (. .))
(S (NP-SBJ (NP (NN ISH)) (PP (IN for) (NP (JJ EBV-encoded) (JJ small) (JJ non-polyadenylated) (NNS RNAs)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (DT all) (NNS cases)) (, ,) (SBAR (IN whether) (FRAG (NP-COOD (NP (NN NK)) (CC or) (NP (NN T))))) (, ,) (VP (VBD harboured) (NP (NN EBV)) (PP (IN in) (NP (ADJP (RB virtually) (DT all)) (NN tumour) (NNS cells))))))) (. .))
(S (NP-SBJ (NN RT-PCR)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NN NL)) (PP (IN of) (NP (DT both) (NNS subtypes)))) (VP (VBD expressed) (NP (NP (NN EBNAI)) (PP (IN of) (NP-COOD (NP (DT the) (NN QUK) (NN splice) (NN pattern)) (, ,) (NP (NP (DT the) (JJ latent) (NN membrane) (NNS proteins)) (, ,) (NP-COOD (NP (NN LMP1)) (CC and) (NP (CD 2)))) (CC and) (NP (DT the) (NN BamHI) (NN A) (JJ rightward) (NNS transcripts))))) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN EBNA2) (NNS mRNAs))) (, ,) (ADJP (JJ compatible) (PP (IN with) (NP (DT the) (NN latency) (NN type) (CD II) (NN pattern)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-79 (NP (NN analysis)) (PP (IN of) (NP (NP (NN EBV) (NN protein) (NN expression)) (PP (IN by) (NP (NN IH)))))) (VP (VBD revealed) (NP (NP (DT a) (JJ heterogeneous) (NN pattern)) (PP (IN of) (NP (NP (NN EBV) (NN gene) (NN expression)) (PP (IN at) (NP (NP (DT the) (NN single-cell) (NN level)) (VP (VBG consisting) (PP (IN of) (NP (ADJP-COOD (CC both) (ADJP (JJ LMP1+)) (CC and) (ADJP (JJ LMP1-))) (NN tumour) (NNS cells))))))))) (, ,) (S (NP-SBJ (-NONE- *-79)) (VP (VBG suggesting) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NN latency) (NP-COOD (NP (CD I)) (CC and) (NP (CD II))))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ-80 (NP (CD 2) (JJ early) (JJ lytic) (NNS transcripts)) (, ,) (NP-COOD (NP (NN BZLF1)) (CC and) (NP (NN BHRF1))) (, ,)) (VP (VBD were) (VP (ADVP (RB also)) (VBN detected) (NP (-NONE- *-80)) (PP (IN in) (NP (NP (QP (CD 13) (CC and) (CD 10)) (NNS cases)) (, ,) (ADVP (RB respectively)))))))) (, ,) (NP-SBJ (NP (DT the) (NN lack)) (PP (IN of) (NP (NN ZEBRA) (NN staining))) (PP (IN in) (NP (DT any) (NN case)))) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ-81 (DT these) (JJ lytic) (NNS transcripts)) (VP (VBP are) (VP (ADVP (RBS most) (RB likely)) (VBN expressed) (NP (-NONE- *-81)) (PP (IN by) (NP-LGS (NP (JJ rare) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NNS biopsies)) (VP (VBG entering) (NP (JJ lytic) (NN cycle)))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ viral) (JJ transcriptional) (NN pattern)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP-COOD (NP (JJ nasopharyngeal) (NN carcinoma)) (CC and) (NP (NP (NN Hodgkin) (POS 's)) (NN disease)))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NN EBV)) (VP (MD can) (VP (VB exploit) (NP (NP (JJ common) (JJ regulatory) (NNS mechanisms)) (PP (IN for) (NP (NN gene) (NN transcription))) (PP (IN in) (NP (JJ diverse) (NN host) (NN cell) (NNS types))))))))) (. .))
(S (NP-SBJ (NP (NN Down-regulation)) (PP (IN of) (NP (NP (JJ immunogenic) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN EBNA2-EBNA6)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ nasal) (NN lymphoma)))) (VP (MD may) (VP (VB enable) (S (NP-SBJ (NN tumour) (NNS cells)) (VP (TO to) (VP (VB evade) (NP (NN host) (JJ cytotoxic) (NN T-cell) (NN surveillance))))))) (. .))
